Key facts
- This page summarizes Jay David Caplan's Form 4 filing for Fractyl Health, Inc. (GUTS).
- 6 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2024, 16:37.
Jay David Caplan - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)
- Reporting relationship
- President, Chief Product Off.
- Issuer ticker
- GUTS
- Reported as of
- 06 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2024, 16:37:24 UTC
- Prior SEC filing
- 01 Feb 2024
- Next SEC filing
- 13 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa A. Davidson, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jay David Caplan filed Form 4 for Fractyl Health, Inc. (GUTS) on 08 Feb 2024.
Change
- Previous filing in this sequence was filed on 01 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GUTS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +23,299
- Change %
- +6.9%
- Price
- Shares after
- 358,806
- Date
- 06 Feb 2024
- Ownership
- By Trust
- Footnotes
- F1, F2
GUTS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +118,810
- Change %
- Price
- Shares after
- 118,810
- Date
- 06 Feb 2024
- Ownership
- By Family Trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GUTS
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- By Trust
- Underlying class
- Common Stock
- Underlying amount
- 23,299
- Exercise price
- Footnotes
- F1, F2
GUTS
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -177,726
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- By Family Trust
- Underlying class
- Common Stock
- Underlying amount
- 82,817
- Exercise price
- Footnotes
- F1
GUTS
transaction
Derivative
Series C-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -44,730
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- By Family Trust
- Underlying class
- Common Stock
- Underlying amount
- 20,843
- Exercise price
- Footnotes
- F1
GUTS
transaction
Derivative
Series C-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -32,514
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- By Family Trust
- Underlying class
- Common Stock
- Underlying amount
- 15,150
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.
Footnote F2
The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust.